BIONDVAX PHARMACEUTICALS LTD's ticker is BVXVW and the CUSIP is 09073Q113. A total of 5 filers reported holding BIONDVAX PHARMACEUTICALS LTD in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $189,000 | +320.0% | 72,800 | 0.0% | 0.27% | +163.4% |
| Q3 2019 | $45,000 | -71.2% | 72,800 | -66.7% | 0.10% | +68.3% |
| Q2 2019 | $156,000 | +524.0% | 218,400 | +200.0% | 0.06% | +150.0% |
| Q1 2019 | $25,000 | -19.4% | 72,800 | 0.0% | 0.02% | -65.2% |
| Q4 2018 | $31,000 | -63.5% | 72,800 | 0.0% | 0.07% | -51.1% |
| Q3 2018 | $85,000 | -7.6% | 72,800 | 0.0% | 0.14% | +22.6% |
| Q2 2018 | $92,000 | +5.7% | 72,800 | 0.0% | 0.12% | -2.5% |
| Q1 2018 | $87,000 | – | 72,800 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|